 Marvin Caruthers
Concepts (374)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA | 44 | 2020 | 1356 | 4.590 |
Why?
| | Oligonucleotides | 22 | 2022 | 137 | 4.030 |
Why?
| | Organophosphorus Compounds | 12 | 2023 | 72 | 3.810 |
Why?
| | Morpholinos | 6 | 2023 | 29 | 2.930 |
Why?
| | Organophosphonates | 8 | 2020 | 91 | 2.680 |
Why?
| | Oligodeoxyribonucleotides | 35 | 2017 | 138 | 2.620 |
Why?
| | Boranes | 6 | 2020 | 6 | 1.700 |
Why?
| | Phosphates | 5 | 2020 | 160 | 1.370 |
Why?
| | Oligonucleotides, Antisense | 7 | 2023 | 100 | 1.270 |
Why?
| | RNA | 12 | 2023 | 819 | 1.260 |
Why?
| | Phosphonoacetic Acid | 6 | 2020 | 10 | 1.200 |
Why?
| | Silver | 3 | 2015 | 27 | 0.970 |
Why?
| | Boron Compounds | 2 | 2015 | 17 | 0.920 |
Why?
| | Amides | 5 | 2017 | 88 | 0.880 |
Why?
| | Phosphoric Acids | 4 | 2017 | 16 | 0.790 |
Why?
| | HeLa Cells | 11 | 2021 | 567 | 0.770 |
Why?
| | Phosphorus | 1 | 2020 | 81 | 0.700 |
Why?
| | Thionucleotides | 9 | 2003 | 34 | 0.610 |
Why?
| | Cations | 2 | 2015 | 79 | 0.610 |
Why?
| | Lac Operon | 13 | 1986 | 46 | 0.590 |
Why?
| | Pyridinium Compounds | 1 | 2017 | 13 | 0.570 |
Why?
| | DNA, Neoplasm | 1 | 2017 | 157 | 0.540 |
Why?
| | MicroRNAs | 2 | 2020 | 607 | 0.530 |
Why?
| | Platinum | 2 | 2013 | 40 | 0.520 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 2 | 2008 | 165 | 0.520 |
Why?
| | Cyclohexenes | 1 | 2015 | 6 | 0.520 |
Why?
| | Oligoribonucleotides | 6 | 2011 | 52 | 0.520 |
Why?
| | Exonucleases | 1 | 2015 | 8 | 0.520 |
Why?
| | Base Sequence | 56 | 2011 | 2114 | 0.510 |
Why?
| | Molecular Structure | 5 | 2020 | 447 | 0.470 |
Why?
| | Chemistry | 7 | 2011 | 39 | 0.460 |
Why?
| | Foscarnet | 2 | 2020 | 18 | 0.450 |
Why?
| | Genes | 23 | 1984 | 224 | 0.450 |
Why?
| | Thymidine | 3 | 2012 | 58 | 0.430 |
Why?
| | Indicators and Reagents | 12 | 2013 | 100 | 0.410 |
Why?
| | RNA Splicing | 7 | 2022 | 244 | 0.410 |
Why?
| | Nanostructures | 1 | 2013 | 99 | 0.400 |
Why?
| | Gold | 1 | 2012 | 107 | 0.390 |
Why?
| | Nucleosides | 2 | 2011 | 25 | 0.390 |
Why?
| | Sulfur Compounds | 1 | 2011 | 5 | 0.390 |
Why?
| | Genetic Techniques | 1 | 2011 | 57 | 0.370 |
Why?
| | Biology | 1 | 2011 | 78 | 0.370 |
Why?
| | Morpholines | 1 | 2011 | 103 | 0.370 |
Why?
| | Oxidation-Reduction | 5 | 2015 | 924 | 0.350 |
Why?
| | Organothiophosphates | 3 | 2003 | 5 | 0.350 |
Why?
| | Repressor Proteins | 11 | 1990 | 369 | 0.350 |
Why?
| | Magnetic Resonance Spectroscopy | 9 | 2015 | 482 | 0.340 |
Why?
| | Solid-Phase Synthesis Techniques | 3 | 2015 | 12 | 0.330 |
Why?
| | Reverse Transcriptase Inhibitors | 4 | 1993 | 82 | 0.320 |
Why?
| | Nucleic Acid Hybridization | 6 | 2015 | 189 | 0.320 |
Why?
| | Escherichia coli | 25 | 1987 | 730 | 0.310 |
Why?
| | Acids | 1 | 2008 | 17 | 0.300 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 746 | 0.300 |
Why?
| | Chemistry Techniques, Synthetic | 2 | 2019 | 13 | 0.290 |
Why?
| | Antiviral Agents | 4 | 1995 | 651 | 0.290 |
Why?
| | Nucleic Acid Conformation | 13 | 2017 | 672 | 0.290 |
Why?
| | Chromatography, High Pressure Liquid | 10 | 2006 | 477 | 0.280 |
Why?
| | Phosphines | 2 | 2020 | 15 | 0.280 |
Why?
| | Molecular Biology | 2 | 2005 | 56 | 0.240 |
Why?
| | Microscopy, Electron, Transmission | 3 | 2015 | 138 | 0.240 |
Why?
| | Cell Nucleus | 3 | 2021 | 553 | 0.240 |
Why?
| | Peroxides | 1 | 2003 | 20 | 0.230 |
Why?
| | History, 20th Century | 3 | 2014 | 273 | 0.230 |
Why?
| | Nonsense Mediated mRNA Decay | 1 | 2023 | 8 | 0.220 |
Why?
| | Muscular Dystrophy, Facioscapulohumeral | 1 | 2023 | 15 | 0.220 |
Why?
| | Biochemistry | 2 | 2001 | 40 | 0.210 |
Why?
| | History, 21st Century | 2 | 2014 | 162 | 0.210 |
Why?
| | DNA, Bacterial | 15 | 1986 | 309 | 0.200 |
Why?
| | Esters | 5 | 2015 | 61 | 0.200 |
Why?
| | Jurkat Cells | 2 | 2015 | 128 | 0.200 |
Why?
| | Nucleic Acid Denaturation | 3 | 2017 | 31 | 0.190 |
Why?
| | Muscular Dystrophy, Duchenne | 1 | 2022 | 81 | 0.190 |
Why?
| | Structure-Activity Relationship | 11 | 2011 | 511 | 0.190 |
Why?
| | Bacteriophage lambda | 4 | 1987 | 81 | 0.190 |
Why?
| | Transcription Factors | 9 | 1997 | 1528 | 0.190 |
Why?
| | Genetic Therapy | 1 | 2022 | 260 | 0.180 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 4 | 2005 | 139 | 0.180 |
Why?
| | DNA, Viral | 6 | 1984 | 351 | 0.180 |
Why?
| | Thymine | 3 | 1995 | 12 | 0.180 |
Why?
| | Polydeoxyribonucleotides | 9 | 1983 | 12 | 0.180 |
Why?
| | RNA, Messenger | 6 | 2022 | 2574 | 0.170 |
Why?
| | Acetic Acid | 1 | 2019 | 16 | 0.170 |
Why?
| | Cell Line | 4 | 2021 | 2651 | 0.170 |
Why?
| | Telomerase | 1 | 2021 | 206 | 0.160 |
Why?
| | Kinetics | 19 | 2001 | 1569 | 0.160 |
Why?
| | HIV-1 | 3 | 1995 | 771 | 0.160 |
Why?
| | RNA, Long Noncoding | 1 | 2021 | 157 | 0.160 |
Why?
| | Operator Regions, Genetic | 2 | 1990 | 6 | 0.160 |
Why?
| | Sulfhydryl Compounds | 3 | 2011 | 178 | 0.160 |
Why?
| | RNA, Transfer | 17 | 1976 | 119 | 0.160 |
Why?
| | Stereoisomerism | 2 | 2015 | 91 | 0.160 |
Why?
| | Molecular Sequence Data | 11 | 1996 | 2790 | 0.150 |
Why?
| | Transition Temperature | 1 | 2017 | 28 | 0.150 |
Why?
| | Temperature | 4 | 2015 | 587 | 0.150 |
Why?
| | Humans | 22 | 2023 | 115587 | 0.140 |
Why?
| | Operon | 6 | 1985 | 59 | 0.140 |
Why?
| | Small Molecule Libraries | 1 | 2017 | 81 | 0.140 |
Why?
| | RNA Precursors | 2 | 2021 | 136 | 0.130 |
Why?
| | Mutation | 15 | 1990 | 3364 | 0.130 |
Why?
| | Nucleotides | 4 | 2015 | 113 | 0.130 |
Why?
| | Antigens, Viral, Tumor | 2 | 1985 | 6 | 0.130 |
Why?
| | Simian virus 40 | 2 | 1985 | 22 | 0.130 |
Why?
| | Molecular Dynamics Simulation | 1 | 2017 | 209 | 0.130 |
Why?
| | Ethylamines | 1 | 2015 | 4 | 0.130 |
Why?
| | Genes, Viral | 4 | 1985 | 89 | 0.120 |
Why?
| | Organothiophosphorus Compounds | 1 | 2014 | 1 | 0.120 |
Why?
| | Huntingtin Protein | 1 | 2014 | 10 | 0.120 |
Why?
| | Iodine | 1 | 2015 | 18 | 0.120 |
Why?
| | Azides | 1 | 2015 | 47 | 0.120 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2015 | 177 | 0.120 |
Why?
| | Dimerization | 1 | 2015 | 177 | 0.120 |
Why?
| | Metal Nanoparticles | 1 | 2015 | 75 | 0.120 |
Why?
| | Solvents | 3 | 2012 | 108 | 0.120 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 4 | 2005 | 312 | 0.110 |
Why?
| | RNA, Catalytic | 3 | 2001 | 182 | 0.110 |
Why?
| | Deoxyribonucleotides | 2 | 1992 | 17 | 0.110 |
Why?
| | Cattle | 2 | 2015 | 935 | 0.110 |
Why?
| | Microarray Analysis | 1 | 2013 | 119 | 0.110 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 2 | 2006 | 238 | 0.110 |
Why?
| | HIV | 2 | 1991 | 209 | 0.110 |
Why?
| | Molecular Mimicry | 1 | 2012 | 35 | 0.100 |
Why?
| | Alcohols | 1 | 2012 | 29 | 0.100 |
Why?
| | Microscopy, Atomic Force | 1 | 2013 | 115 | 0.100 |
Why?
| | DNA-Directed RNA Polymerases | 4 | 1987 | 52 | 0.100 |
Why?
| | Nobel Prize | 1 | 2011 | 4 | 0.100 |
Why?
| | Plasmids | 6 | 1985 | 345 | 0.100 |
Why?
| | Organophosphates | 1 | 2012 | 90 | 0.100 |
Why?
| | Models, Biological | 3 | 2011 | 1646 | 0.100 |
Why?
| | Promoter Regions, Genetic | 3 | 1987 | 1122 | 0.100 |
Why?
| | Animals | 12 | 2022 | 32102 | 0.100 |
Why?
| | Molecular Weight | 2 | 2008 | 329 | 0.100 |
Why?
| | Deoxycytidine | 1 | 1992 | 140 | 0.100 |
Why?
| | Combinatorial Chemistry Techniques | 1 | 2011 | 17 | 0.100 |
Why?
| | Transcription, Genetic | 17 | 1991 | 1310 | 0.090 |
Why?
| | Cell Membrane Permeability | 1 | 2011 | 83 | 0.090 |
Why?
| | Alanine | 7 | 1972 | 103 | 0.090 |
Why?
| | Polynucleotides | 8 | 1975 | 13 | 0.090 |
Why?
| | Nucleic Acid Heteroduplexes | 2 | 2007 | 8 | 0.090 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 544 | 0.080 |
Why?
| | Cloning, Molecular | 6 | 1990 | 523 | 0.080 |
Why?
| | Water | 1 | 2012 | 412 | 0.080 |
Why?
| | Purines | 1 | 2010 | 159 | 0.080 |
Why?
| | Binding Sites | 10 | 1985 | 1177 | 0.080 |
Why?
| | Reproducibility of Results | 2 | 2008 | 2800 | 0.080 |
Why?
| | Nanoparticles | 1 | 2012 | 316 | 0.080 |
Why?
| | Genetic Code | 3 | 1977 | 20 | 0.080 |
Why?
| | Lactose Factors | 2 | 1977 | 2 | 0.070 |
Why?
| | Ribonuclease H | 3 | 2003 | 11 | 0.070 |
Why?
| | Transfection | 2 | 2007 | 866 | 0.070 |
Why?
| | Esterification | 1 | 2007 | 15 | 0.070 |
Why?
| | Polymerase Chain Reaction | 1 | 2010 | 1000 | 0.070 |
Why?
| | United States | 2 | 2014 | 12295 | 0.070 |
Why?
| | Receptors, Cyclic AMP | 2 | 1984 | 2 | 0.070 |
Why?
| | Saccharomyces cerevisiae | 5 | 1972 | 482 | 0.070 |
Why?
| | DNA-Binding Proteins | 3 | 1997 | 1316 | 0.070 |
Why?
| | Nuclear Proteins | 1 | 1991 | 594 | 0.070 |
Why?
| | Flow Cytometry | 3 | 2007 | 1083 | 0.070 |
Why?
| | Biophysical Phenomena | 1 | 2006 | 63 | 0.070 |
Why?
| | Models, Chemical | 2 | 2005 | 257 | 0.070 |
Why?
| | Biophysics | 1 | 2006 | 70 | 0.060 |
Why?
| | Oncogene Proteins, Viral | 1 | 1985 | 20 | 0.060 |
Why?
| | Deoxyribonuclease I | 3 | 2003 | 34 | 0.060 |
Why?
| | Polynucleotide Ligases | 7 | 1977 | 8 | 0.060 |
Why?
| | Thermodynamics | 7 | 2001 | 388 | 0.060 |
Why?
| | Mass Spectrometry | 3 | 2005 | 645 | 0.060 |
Why?
| | Lithium Chloride | 1 | 2005 | 11 | 0.060 |
Why?
| | Acetonitriles | 1 | 2005 | 8 | 0.060 |
Why?
| | Genetic Engineering | 1 | 1985 | 81 | 0.060 |
Why?
| | Chromatography, Ion Exchange | 2 | 2003 | 48 | 0.060 |
Why?
| | Macromolecular Substances | 1 | 2005 | 200 | 0.060 |
Why?
| | In Vitro Techniques | 2 | 2022 | 1044 | 0.060 |
Why?
| | Automation | 1 | 2004 | 74 | 0.060 |
Why?
| | Genes, Bacterial | 1 | 1984 | 156 | 0.060 |
Why?
| | Polymers | 3 | 2005 | 464 | 0.060 |
Why?
| | Anions | 1 | 2003 | 31 | 0.060 |
Why?
| | Gene Expression Regulation | 5 | 2023 | 2353 | 0.060 |
Why?
| | Chemical Phenomena | 6 | 1986 | 81 | 0.060 |
Why?
| | Introns | 3 | 2021 | 226 | 0.060 |
Why?
| | Protein Kinases | 1 | 1985 | 306 | 0.060 |
Why?
| | Cell Compartmentation | 2 | 2021 | 52 | 0.060 |
Why?
| | Serine-Arginine Splicing Factors | 1 | 2023 | 19 | 0.060 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 1718 | 0.050 |
Why?
| | Lactose | 3 | 1977 | 6 | 0.050 |
Why?
| | Lipids | 1 | 2007 | 588 | 0.050 |
Why?
| | Mice, Inbred mdx | 1 | 2022 | 11 | 0.050 |
Why?
| | HIV Reverse Transcriptase | 2 | 1993 | 29 | 0.050 |
Why?
| | Polyethylene Glycols | 2 | 2005 | 576 | 0.050 |
Why?
| | DNA, Circular | 1 | 1982 | 13 | 0.050 |
Why?
| | DNA Restriction Enzymes | 5 | 1985 | 54 | 0.050 |
Why?
| | Enzyme Activation | 2 | 1996 | 793 | 0.050 |
Why?
| | DNA Adducts | 1 | 2001 | 15 | 0.050 |
Why?
| | Human Embryonic Stem Cells | 1 | 2021 | 18 | 0.050 |
Why?
| | HCT116 Cells | 1 | 2021 | 69 | 0.050 |
Why?
| | Single-Strand Specific DNA and RNA Endonucleases | 2 | 1996 | 10 | 0.050 |
Why?
| | Tetrahymena thermophila | 1 | 2001 | 58 | 0.050 |
Why?
| | Mice | 5 | 2022 | 15052 | 0.050 |
Why?
| | Species Specificity | 2 | 2021 | 552 | 0.050 |
Why?
| | RNA Stability | 1 | 2021 | 93 | 0.040 |
Why?
| | Mitosis | 1 | 2021 | 164 | 0.040 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2021 | 310 | 0.040 |
Why?
| | RNA-Binding Proteins | 1 | 2023 | 362 | 0.040 |
Why?
| | Hypoxanthines | 1 | 1979 | 4 | 0.040 |
Why?
| | DNA Polymerase I | 1 | 1979 | 26 | 0.040 |
Why?
| | DNA-Directed DNA Polymerase | 1 | 1979 | 44 | 0.040 |
Why?
| | Coliphages | 7 | 1984 | 7 | 0.040 |
Why?
| | Adenoviruses, Human | 3 | 1984 | 24 | 0.040 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 183 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 602 | 0.040 |
Why?
| | Base Composition | 4 | 1987 | 76 | 0.040 |
Why?
| | Methods | 3 | 1983 | 58 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2014 | 3914 | 0.040 |
Why?
| | Genes, Regulator | 1 | 1977 | 33 | 0.040 |
Why?
| | Genes, Synthetic | 2 | 1987 | 14 | 0.030 |
Why?
| | DNA, Antisense | 1 | 1995 | 3 | 0.030 |
Why?
| | Trityl Compounds | 1 | 1995 | 3 | 0.030 |
Why?
| | Genes, erbB-2 | 1 | 1995 | 26 | 0.030 |
Why?
| | Hot Temperature | 2 | 1991 | 303 | 0.030 |
Why?
| | Tyrosine | 11 | 1982 | 219 | 0.030 |
Why?
| | Viral Proteins | 3 | 1985 | 286 | 0.030 |
Why?
| | Protein Binding | 5 | 1997 | 1917 | 0.030 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 1996 | 225 | 0.030 |
Why?
| | Herpesvirus 1, Human | 1 | 1995 | 78 | 0.030 |
Why?
| | Time Factors | 2 | 2004 | 6165 | 0.030 |
Why?
| | Huntington Disease | 1 | 2014 | 38 | 0.030 |
Why?
| | Receptor, ErbB-2 | 1 | 1996 | 302 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2021 | 2751 | 0.030 |
Why?
| | Microbial Sensitivity Tests | 1 | 1995 | 299 | 0.030 |
Why?
| | Peptides | 1 | 1979 | 864 | 0.030 |
Why?
| | Chemistry, Organic | 2 | 1993 | 6 | 0.030 |
Why?
| | Catalysis | 3 | 2001 | 299 | 0.030 |
Why?
| | Virus Replication | 3 | 1992 | 396 | 0.030 |
Why?
| | Mercaptoethanol | 1 | 1993 | 11 | 0.030 |
Why?
| | Tumor Cells, Cultured | 3 | 2003 | 850 | 0.030 |
Why?
| | Guanine | 2 | 1986 | 76 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2022 | 3580 | 0.030 |
Why?
| | Cytopathogenic Effect, Viral | 1 | 1992 | 16 | 0.030 |
Why?
| | Leukocytes, Mononuclear | 1 | 1995 | 501 | 0.030 |
Why?
| | Cell Fusion | 1 | 1992 | 50 | 0.030 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 1992 | 18 | 0.030 |
Why?
| | Tetrahymena | 1 | 1993 | 155 | 0.030 |
Why?
| | Amino Acid Sequence | 4 | 1990 | 2000 | 0.020 |
Why?
| | Pancreatic Neoplasms | 1 | 1997 | 722 | 0.020 |
Why?
| | Antibodies | 2 | 1990 | 374 | 0.020 |
Why?
| | Substrate Specificity | 2 | 2001 | 357 | 0.020 |
Why?
| | DNA Ligases | 2 | 1979 | 15 | 0.020 |
Why?
| | Protein Biosynthesis | 8 | 1976 | 390 | 0.020 |
Why?
| | Half-Life | 2 | 1978 | 145 | 0.020 |
Why?
| | Spectrum Analysis | 2 | 1986 | 80 | 0.020 |
Why?
| | Magnesium | 2 | 2000 | 145 | 0.020 |
Why?
| | Uracil | 1 | 1986 | 31 | 0.020 |
Why?
| | Antigens, Polyomavirus Transforming | 1 | 1985 | 14 | 0.020 |
Why?
| | Chromosome Mapping | 2 | 1979 | 489 | 0.020 |
Why?
| | Silicon Dioxide | 2 | 1986 | 94 | 0.020 |
Why?
| | Methylation | 1 | 1986 | 206 | 0.020 |
Why?
| | Breast Neoplasms | 1 | 1996 | 1872 | 0.020 |
Why?
| | Viral Regulatory and Accessory Proteins | 1 | 1985 | 27 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2003 | 515 | 0.020 |
Why?
| | DNA, Recombinant | 1 | 1984 | 42 | 0.020 |
Why?
| | Adenosine Triphosphate | 4 | 1976 | 431 | 0.020 |
Why?
| | Spectrophotometry | 2 | 1983 | 48 | 0.020 |
Why?
| | Electron Transport Complex IV | 1 | 1984 | 53 | 0.010 |
Why?
| | Isomerism | 1 | 1984 | 42 | 0.010 |
Why?
| | Protein Precursors | 1 | 1984 | 119 | 0.010 |
Why?
| | Poly A | 1 | 1983 | 46 | 0.010 |
Why?
| | Circular Dichroism | 1 | 2003 | 135 | 0.010 |
Why?
| | Isopropyl Thiogalactoside | 1 | 1982 | 1 | 0.010 |
Why?
| | Chromatography, DEAE-Cellulose | 2 | 1972 | 14 | 0.010 |
Why?
| | Thioglycosides | 1 | 1982 | 2 | 0.010 |
Why?
| | RNA, Viral | 2 | 1983 | 565 | 0.010 |
Why?
| | Color | 1 | 1983 | 75 | 0.010 |
Why?
| | Adenoviridae | 1 | 1983 | 186 | 0.010 |
Why?
| | Chromatography | 1 | 1982 | 24 | 0.010 |
Why?
| | Deoxyribonuclease EcoRI | 1 | 1982 | 5 | 0.010 |
Why?
| | Silica Gel | 1 | 1982 | 1 | 0.010 |
Why?
| | Chemical Precipitation | 1 | 1982 | 38 | 0.010 |
Why?
| | Models, Genetic | 1 | 1985 | 570 | 0.010 |
Why?
| | Endonucleases | 1 | 1982 | 30 | 0.010 |
Why?
| | Protein Conformation | 1 | 1985 | 822 | 0.010 |
Why?
| | Molecular Probes | 1 | 2001 | 30 | 0.010 |
Why?
| | Phosphorylation | 1 | 1984 | 1571 | 0.010 |
Why?
| | Phenotype | 2 | 1985 | 2829 | 0.010 |
Why?
| | Cadmium | 1 | 2000 | 58 | 0.010 |
Why?
| | Sulfur | 1 | 2000 | 45 | 0.010 |
Why?
| | Static Electricity | 1 | 2000 | 117 | 0.010 |
Why?
| | T-Phages | 1 | 1979 | 22 | 0.010 |
Why?
| | Peptide Biosynthesis | 1 | 1979 | 13 | 0.010 |
Why?
| | Poly dA-dT | 1 | 1979 | 2 | 0.010 |
Why?
| | Cytosine | 1 | 1979 | 44 | 0.010 |
Why?
| | Polynucleotide 5'-Hydroxyl-Kinase | 2 | 1976 | 2 | 0.010 |
Why?
| | Metals | 1 | 2000 | 109 | 0.010 |
Why?
| | Phosphoric Monoester Hydrolases | 2 | 1976 | 54 | 0.010 |
Why?
| | Bromouracil | 1 | 1978 | 1 | 0.010 |
Why?
| | Proteins | 1 | 1984 | 920 | 0.010 |
Why?
| | HIV Infections | 1 | 1992 | 2473 | 0.010 |
Why?
| | Chromatography, Gel | 3 | 1972 | 128 | 0.010 |
Why?
| | Adenine | 1 | 1979 | 221 | 0.010 |
Why?
| | DNA Replication | 4 | 1984 | 203 | 0.010 |
Why?
| | Lysogeny | 1 | 1977 | 3 | 0.010 |
Why?
| | Osmolar Concentration | 1 | 1977 | 178 | 0.010 |
Why?
| | Genes, ras | 1 | 1997 | 91 | 0.010 |
Why?
| | Binding, Competitive | 1 | 1997 | 200 | 0.010 |
Why?
| | Neoplasm Transplantation | 1 | 1997 | 235 | 0.010 |
Why?
| | Blood Chemical Analysis | 1 | 1997 | 90 | 0.010 |
Why?
| | Area Under Curve | 1 | 1997 | 278 | 0.010 |
Why?
| | Suppression, Genetic | 2 | 1973 | 23 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1997 | 324 | 0.010 |
Why?
| | Hydrogen Bonding | 2 | 1986 | 145 | 0.010 |
Why?
| | Drug Stability | 2 | 1986 | 152 | 0.010 |
Why?
| | Spectrophotometry, Ultraviolet | 4 | 1976 | 75 | 0.010 |
Why?
| | Muscles | 1 | 1997 | 326 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2000 | 1870 | 0.010 |
Why?
| | Isotope Labeling | 2 | 1972 | 76 | 0.010 |
Why?
| | Oxygen | 1 | 2000 | 837 | 0.010 |
Why?
| | Fluorescein-5-isothiocyanate | 1 | 1995 | 37 | 0.010 |
Why?
| | Chromatography, Paper | 2 | 1972 | 3 | 0.010 |
Why?
| | G1 Phase | 1 | 1995 | 68 | 0.010 |
Why?
| | Mice, Nude | 1 | 1997 | 639 | 0.010 |
Why?
| | Spleen | 1 | 1997 | 492 | 0.010 |
Why?
| | Calorimetry | 2 | 1986 | 62 | 0.010 |
Why?
| | Cell Separation | 1 | 1995 | 293 | 0.010 |
Why?
| | 3T3 Cells | 1 | 1994 | 137 | 0.010 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 1994 | 53 | 0.010 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 1994 | 83 | 0.010 |
Why?
| | Iodine Radioisotopes | 1 | 1994 | 126 | 0.010 |
Why?
| | Lipopolysaccharide Receptors | 1 | 1994 | 81 | 0.010 |
Why?
| | Solubility | 1 | 1994 | 226 | 0.010 |
Why?
| | Peptide Chain Termination, Translational | 1 | 1973 | 5 | 0.010 |
Why?
| | Down-Regulation | 1 | 1995 | 601 | 0.010 |
Why?
| | Isoenzymes | 1 | 1994 | 285 | 0.010 |
Why?
| | Ribonucleotides | 1 | 1973 | 25 | 0.010 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 1973 | 38 | 0.010 |
Why?
| | Biological Transport | 1 | 1994 | 375 | 0.010 |
Why?
| | Manganese | 1 | 1993 | 55 | 0.010 |
Why?
| | Protein Kinase C | 1 | 1994 | 274 | 0.010 |
Why?
| | RNA, Bacterial | 1 | 1973 | 173 | 0.010 |
Why?
| | Antigens, CD | 1 | 1994 | 442 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 1994 | 1243 | 0.010 |
Why?
| | Computers | 2 | 1984 | 60 | 0.010 |
Why?
| | Zinc | 1 | 1993 | 256 | 0.010 |
Why?
| | Kidney | 1 | 1997 | 1207 | 0.010 |
Why?
| | Antibody Affinity | 1 | 1990 | 52 | 0.010 |
Why?
| | Radioimmunoassay | 1 | 1990 | 163 | 0.010 |
Why?
| | Antibody Specificity | 1 | 1990 | 176 | 0.010 |
Why?
| | Rabbits | 1 | 1990 | 752 | 0.000 |
Why?
| | Antibody Formation | 1 | 1990 | 273 | 0.000 |
Why?
| | Propionates | 1 | 1967 | 33 | 0.000 |
Why?
| | DNA Nucleotidyltransferases | 3 | 1972 | 11 | 0.000 |
Why?
| | Phosphorus Radioisotopes | 1 | 1986 | 28 | 0.000 |
Why?
| | RNA, Double-Stranded | 1 | 1986 | 44 | 0.000 |
Why?
| | Ligases | 3 | 1972 | 32 | 0.000 |
Why?
| | Solutions | 1 | 1986 | 150 | 0.000 |
Why?
| | Autoanalysis | 1 | 1984 | 6 | 0.000 |
Why?
| | Phenylthiohydantoin | 1 | 1984 | 40 | 0.000 |
Why?
| | Templates, Genetic | 1 | 1983 | 59 | 0.000 |
Why?
| | Cytoplasm | 1 | 1984 | 255 | 0.000 |
Why?
| | Buffers | 1 | 1982 | 54 | 0.000 |
Why?
| | Phosphorus Isotopes | 2 | 1972 | 8 | 0.000 |
Why?
| | Phosphotransferases | 2 | 1972 | 25 | 0.000 |
Why?
| | Alkaline Phosphatase | 2 | 1972 | 144 | 0.000 |
Why?
| | Peptide Fragments | 1 | 1982 | 675 | 0.000 |
Why?
| | Liver | 1 | 1984 | 1690 | 0.000 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 1976 | 44 | 0.000 |
Why?
| | Evaluation Studies as Topic | 1 | 1975 | 169 | 0.000 |
Why?
| | Adenosine Diphosphate | 1 | 1972 | 81 | 0.000 |
Why?
| | Genetics, Microbial | 1 | 1970 | 9 | 0.000 |
Why?
| | Female | 1 | 1996 | 59913 | 0.000 |
Why?
| | Yeasts | 1 | 1970 | 51 | 0.000 |
Why?
| | RNA Nucleotidyltransferases | 1 | 1968 | 24 | 0.000 |
Why?
| | Benzoates | 1 | 1967 | 38 | 0.000 |
Why?
| | Organic Chemistry Phenomena | 1 | 1967 | 2 | 0.000 |
Why?
| | Alkalies | 1 | 1967 | 7 | 0.000 |
Why?
| | Enzymes | 1 | 1968 | 61 | 0.000 |
Why?
| | Electrophoresis | 1 | 1967 | 25 | 0.000 |
Why?
| | Ultraviolet Rays | 1 | 1967 | 372 | 0.000 |
Why?
|
|
Caruthers's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|